awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q90304141-106F31D9-95F8-4D74-A8F2-A7241ED827C6
Q90304141-106F31D9-95F8-4D74-A8F2-A7241ED827C6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q90304141-106F31D9-95F8-4D74-A8F2-A7241ED827C6
Tolerance and efficacy of BRAF plus MEK inhibition in patients with melanoma who previously have received programmed cell death protein 1-based therapy
P577
Q90304141-106F31D9-95F8-4D74-A8F2-A7241ED827C6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q90304141-106F31D9-95F8-4D74-A8F2-A7241ED827C6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8ea5cbee07029dd0d939bf337813d60f8f755f48
P577
2018-12-06T00:00:00Z
http://www.w3.org/2001/XMLSchema#dateTime
P577
936163a6c97093935454bfebde635ed7